The goal of this clinical trial is to test in the clinical effect of long round needle in the treatment of cervical spondylotic radiculopathy, and analyze its safety and its influence on pain and functional recovery. The main question it aims to answer is whether long round needle therapy for patients with cervical spondylotic radiculopathy is effective and safe. Participants will be selected as the research objects. They will randomly divided into control group (n = 49) and observation group (n = 49). The control group was treated with filiform needle, and the observation group was treated with long round needle. Researchers will compare the two groups to see the differences on the therapeutic effect, safety, Neck dysfunction index (NDI), pain score (McGill pain questionnaire, MPQ), quality of life (Generic Quality of Life Inventory-74, GQOL-74), and levels of inflammatory factors.
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Neck dysfunction index (NDI)
Timeframe: Before treament
Neck dysfunction index (NDI)
Timeframe: Through study completion, an average of 1 year and 10 months
McGill pain questionnaire (MPQ) score
Timeframe: Before treament
McGill pain questionnaire (MPQ) score
Timeframe: Through study completion, an average of 1 year and 10 months
comprehensive assessment questionnaire (GQOL-74) scale
Timeframe: Before treament
comprehensive assessment questionnaire (GQOL-74) scale
Timeframe: Through study completion, an average of 1 year and 10 months
interleukin-8 (IL-8) level
Timeframe: Before treament
interleukin-8 (IL-8) level
Timeframe: Through study completion, an average of 1 year and 10 months
interleukin-10 (IL-10) level
Timeframe: Before treament
interleukin-10 (IL-10) level
Timeframe: Through study completion, an average of 1 year and 10 months